Join
Live feed
·
INSIDERFilingvia Quantisnow
Blueprint Medicines Corporation logo

PRESIDENT, R & D Namouni Fouad was granted 39,456 shares and returned 83,281 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BPMC· Blueprint Medicines Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BPMC (Blueprint Medicines Corporation) and more on Quantisnow.